† One patient had MMF as an initial treatment. ‡ In the study TAC and MMF were used alone or in combination. §In total, 17 patients were initially treated with MMF and steroids. ¶ Females ...

The data discussed earlier indicate that MMF may have value as an alternative treatment for AIH patients who do not respond to standard treatment. However, more data are required. Randomized ...

Objectives To report the 10-year outcome of lupus nephritis (LN) treated with mycophenolate mofetil (MMF) or tacrolimus (TAC) induction in a randomised controlled trial. Methods Patients with active ...

The following is a summary of “Comparative effectiveness of disease modifying antirheumatic drugs for patients with cardiac ...

Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, USA Correspondence to Dr K R Sharma, Department of Neurology, University of Miami, Miller School of Medicine ...

1 The purpose of ALMS was to demonstrate the superiority of mycophenolate mofetil (MMF) over intravenous cyclophosphamide for the induction of remission in patients with lupus nephritis.

While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell ...

Sex-related differences in pulmonary complications were found among men vs women with SSc, specifically in the prevalence of ILD and SAD.

Objective To explore the efficacy of initial treatment of newly diagnosed childhood-onset lupus nephritis (cLN) with combination of belimumab and either cyclophosphamide, mycophenolate mofetil, ...

The antiviral drug valaciclovir (Valtrex), given prophylactically, kept patients with systemic lupus erythematosus (SLE) ...

Methotrexate was replaced by pulsed intravenous methylprednisolone (1 g daily for 3 days), followed by mycophenolate mofetil started at 1 g per day and titrated up over 4 weeks to 3 g per day.